1FW2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - WuXi Biologics (Cayman) Inc

Watchlist Manager

Watchlist

Price: 4.35 EUR 1.16% Market Closed

Market Cap: €18.1B

	WuXi Biologics (Cayman) Inc F:1FW2	CN
	Zehnder Group AG F:ZEH2	CH
B	Bper Banca SpA SWB:4BE	IT
M	MorphoSys AG XBER:MOR	DE
S	Super Bank Indonesia Tbk PT IDX:SUPA	ID
	HTC Corp F:HTJ	TW
L	Liberty Global PLC NASDAQ:LBTYB	UK
	DWS Group GmbH & Co KgaA F:DWS	DE

Profitability Summary

WuXi Biologics (Cayman) Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

46%

Sustainable 3Y Average Gross Margin

42%

Gross Margin is Increasing

42% > 46%

Exceptional Operating Margin

31%

Sustainable 3Y Average Operating Margin

26%

Operating Margin is Increasing

26% > 31%

Healthy Net Margin

23%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

25% > 23%

Exceptional Free Cash Flow Margin

12%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.